The University of Queensland

Global non-interventional study (NIS) to understand the clinical management of difficult to treat patients with locally advanced basal cell carcinoma (LaBCC) - Retrospective medical chart review (2015–2016)

Grant type:

Novartis Pharmaceuticals Australia Pty Limited

Researchers:

• 

  Professor Peter Soyer

  MRFF-NG Practitioner Fellow
  

  Frazer Institute

  Faculty of Medicine

Funded by:

Novartis Pharmaceuticals Australia Pty Limited